These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 28842957)

  • 1. Understanding Epigenetic Effects of Endocrine Disrupting Chemicals: From Mechanisms to Novel Test Methods.
    Alavian-Ghavanini A; Rüegg J
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):38-45. PubMed ID: 28842957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals.
    Stel J; Legler J
    Endocrinology; 2015 Oct; 156(10):3466-72. PubMed ID: 26241072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental epigenomics: Current approaches to assess epigenetic effects of endocrine disrupting compounds (EDC's) on human health.
    Tapia-Orozco N; Santiago-Toledo G; Barrón V; Espinosa-García AM; García-García JA; García-Arrazola R
    Environ Toxicol Pharmacol; 2017 Apr; 51():94-99. PubMed ID: 28215500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multigenerational and transgenerational effects of endocrine disrupting chemicals: A role for altered epigenetic regulation?
    Xin F; Susiarjo M; Bartolomei MS
    Semin Cell Dev Biol; 2015 Jul; 43():66-75. PubMed ID: 26026600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Modifications Associated with Exposure to Endocrine Disrupting Chemicals in Patients with Gestational Diabetes Mellitus.
    Kunysz M; Mora-Janiszewska O; Darmochwał-Kolarz D
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics, estrogenic endocrine-disrupting chemicals (EDCs), and the brain.
    Streifer M; Gore AC
    Adv Pharmacol; 2021; 92():73-99. PubMed ID: 34452697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic impacts of endocrine disruptors in the brain.
    Walker DM; Gore AC
    Front Neuroendocrinol; 2017 Jan; 44():1-26. PubMed ID: 27663243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular features of EDC exposure: consequences for the GnRH network.
    Lopez-Rodriguez D; Franssen D; Bakker J; Lomniczi A; Parent AS
    Nat Rev Endocrinol; 2021 Feb; 17(2):83-96. PubMed ID: 33288917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modifications associated with in utero exposure to endocrine disrupting chemicals BPA, DDT and Pb.
    Onuzulu CD; Rotimi OA; Rotimi SO
    Rev Environ Health; 2019 Dec; 34(4):309-325. PubMed ID: 31271561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking inter-individual variability to endocrine disruptors: insights for epigenetic inheritance.
    Latchney SE; Fields AM; Susiarjo M
    Mamm Genome; 2018 Feb; 29(1-2):141-152. PubMed ID: 29218402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics and pesticides.
    Collotta M; Bertazzi PA; Bollati V
    Toxicology; 2013 May; 307():35-41. PubMed ID: 23380243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenerational epigenetic effects from male exposure to endocrine-disrupting compounds: a systematic review on research in mammals.
    Van Cauwenbergh O; Di Serafino A; Tytgat J; Soubry A
    Clin Epigenetics; 2020 May; 12(1):65. PubMed ID: 32398147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Epigenetics and Environmental Health: Making a Case for Endocrine Disrupting Chemicals.
    Zhou Z; Goodrich JM; Strakovsky RS
    Toxicol Sci; 2020 Nov; 178(1):16-25. PubMed ID: 32777053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental factors, epigenetics, and developmental origin of reproductive disorders.
    Ho SM; Cheong A; Adgent MA; Veevers J; Suen AA; Tam NNC; Leung YK; Jefferson WN; Williams CJ
    Reprod Toxicol; 2017 Mar; 68():85-104. PubMed ID: 27421580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From bench to bedside: Biosensing strategies to evaluate endocrine disrupting compounds based on epigenetic events and their potential use in medicine.
    Araiza-Olivera D; Gutierrez-Aguilar M; Espinosa-García AM; García-García JA; Tapia-Orozco N; Sánchez-Pérez C; Palacios-Reyes C; Escárcega D; Villalón-López DN; García-Arrazola R
    Environ Toxicol Pharmacol; 2020 Nov; 80():103450. PubMed ID: 32622887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effects of environmental endocrine disrupting chemicals.
    Kuo CH; Yang SN; Kuo PL; Hung CH
    Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S37-42. PubMed ID: 22871600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minireview: Epigenomic Plasticity and Vulnerability to EDC Exposures.
    Walker CL
    Mol Endocrinol; 2016 Aug; 30(8):848-55. PubMed ID: 27355193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Endocrine Disruptors upon Non-Genetic Inheritance.
    Montjean D; Neyroud AS; Yefimova MG; Benkhalifa M; Cabry R; Ravel C
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epigenome-wide association study identifies multiple DNA methylation markers of exposure to endocrine disruptors.
    Lu X; Fraszczyk E; van der Meer TP; van Faassen M; Bloks VW; Kema IP; van Beek AP; Li S; Franke L; Westra HJ; ; Xu X; Huo X; Snieder H; Wolffenbuttel BHR; van Vliet-Ostaptchouk JV
    Environ Int; 2020 Nov; 144():106016. PubMed ID: 32916427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational exposure to low-dose zearalenone disrupting offspring spermatogenesis might be through epigenetic modifications.
    Men Y; Zhao Y; Zhang P; Zhang H; Gao Y; Liu J; Feng Y; Li L; Shen W; Sun Z; Min L
    Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):382-393. PubMed ID: 31058416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.